Search bioRxiv⌕ Search

Biology subjects

Sasai, T.

Publications and source records attributed to Sasai, T..

2 recordsLinked to original sources

Integrative taxonomic revision of turtle barnacle genus Platylepas (Cirripedia: Coronuloidea): an ancient host-range expansion to sea snakes and sirenians

The barnacle genus Platylepas contains obligate epibionts of marine vertebrates, but the taxonomic status and evolutionary history of the sea-snake specialist, P. ophiophila, have remained unclear. Here, we reassess species boundaries and host associations in Platylepas using shell-morphological comparisons and sequence data from mitochondrial COI and nuclear H3 genes from specimens collected from sea turtles, sea snakes, and a dugong. Our results show that P. ophiophila is a valid species, phylogenetically and morphologically distinct from the widespread turtle barnacles P. decorata and P. hexastylos. Furthermore, we report the first record of P. ophiophila from a sirenian host (Dugong dugon), a discovery that necessitates the re-examination of historical records of barnacles on sirenians worldwide. Our phylogeny places P. decorata, a turtle epibiont, as the earliest diverging lineage within the genus. This is consistent with the hypothesis that the ancestor of Platylepas was associated with sea turtles, a conclusion supported by the ichnofossil record. The subsequent divergence of the P. ophiophila clade may represent an important host-use transition: an ancient host shift from sea turtles to the taxonomically disparate but ecologically linked inhabitants--sea snakes and sirenians--of seagrass ecosystems. This study clarifies species limits within Platylepas and provides a framework for discussing host associations and potential host shifts in light of existing molecular and fossil evidence.

zoology↗

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides

IF7 peptide, which binds to the annexin A1 (ANXA1) N-terminal domain, functions as a tumor vasculature-targeted drug delivery vehicle after intravenous injection. To enhance IF7 stability in vivo, we undertook mirror-image peptide phage display using a synthetic D-peptide representing the Anxa1 N-terminus as target. Peptide sequences were identified, synthesized as D-amino acids, and designated as dTIT7, which was shown to bind the ANXA1 N-terminus. Whole body imaging of mouse brain tumors modeled with near infrared fluorescent IRDye-conjugated dTIT7 showed fluorescent signals in brain and kidney. Furthermore, orally-administered geldanamycin (GA)-conjugated dTIT7 suppressed brain tumor growth. Ours is a proof-of-concept experiment showing that Anxa1-binding D-peptide could be developed as an orally-administrable, tumor vasculature-targeted therapeutic. Role of each author: MN designed and performed experiments, analyzed data, and wrote the manuscript; HMA and DLJ produced recombinant ANXA1 protein; KY conducted NMR analysis and data analysis; TOA designed, performed and analyzed LC-MS/MS data; MN, TS, IKT, YS, and TY analyzed peptide-binding assays and performed in silico structural analysis; CTU produced lentivirus for luciferase expression; CNH performed peptide binding assays, tissue culture and animal experiments; and MNF supervised the project and wrote the manuscript.

pharmacology and toxicology↗